Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
ACTIVE RFPs
| Title | Grant Type | Focus Area | Country | Application Due Date |
|---|---|---|---|---|
2021 Growth Hormone Research (United States) Release Date: | Research | Rare Disease | USA | |
Acromegaly Release Date: | Research | Rare Disease | USA | |
Pediatric Endocrinology Fellowship Release Date: | Fellowship | Rare Disease | USA | |
Providing Access to Learning Resources for Tobacco Dependence Treatment | Education | Internal Medicine | Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, South Africa, United Arab Emirates | |
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Release Date: | Education | Rare Disease | USA | |
Transthyretin Cardiac Amyloidosis Fellowship Release Date: | Fellowship | Rare Disease | USA | |
Employment Support / Lung Cancer Release Date: | Education | Oncology | Japan | |
Biomarker Testing / Lung Cancer Release Date: | Education | Oncology | Japan | |
Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism Release Date: | Quality Improvement | Internal Medicine | Japan | |
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation Release Date: | Education | Internal Medicine | Japan | |
Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism Release Date: | Education | Internal Medicine | Japan | |
Pre-clinical & Translational Research in Multiple Myeloma Release Date: | Research | Oncology | Canada, USA | |
Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease Release Date: | Quality Improvement | Rare Disease | All | |
Promotion of Smoking Cessation Treatment in General Practice Release Date: | Education | Internal Medicine | Japan | |
2021 Growth Hormone Research (All countries except for the United States) Release Date: | Research | Rare Disease | All | |
Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain | Education | Internal Medicine | All | |
Clinical Research Capability Development Release Date: | Education | Internal Medicine | China | |
Educational Program to Increase Awareness and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Release Date: | Education | Rare Disease | China | |
Quality Improvement in Pediatric Endocrinology fields Release Date: Partner: The Japanese Society for Pediatric Endocrinology | Quality Improvement | Rare Disease | Japan | |
Advances in Immuno-Oncology Therapy in Urothelial Cancer Release Date: | Education | Oncology | Japan | |
Imaging Diagnostics for Differentiating Cardiac Amyloidosis Release Date: | Education | Rare Disease | Japan | |
Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown Cause Release Date: | Education | Rare Disease | Japan | |
Improving Treatment Environment for Chronic Myeloid Leukemia (CML) Release Date: | Education | Oncology | Japan | |
Atrial Fibrillation and Venous Thromboembolism (excluding United States) | Education | Internal Medicine | All | |
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers Release Date: | Research | Inflammation & Immunology | France, Germany, Italy, Japan, Spain, United Kingdom | |
China Breast Cancer Landscape – Educational Needs Assessment Release Date: | Education | Oncology | China | |
Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic Dermatitis Release Date: | Education | Inflammation & Immunology | Japan | |
Addressing Primary Immunodeficiencies within Minority/Underserved Populations Release Date: | Education | Hospital | USA | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S. Release Date: | Research | Rare Disease | USA | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant Program Release Date: | Quality Improvement | Rare Disease | USA | |
Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe) Release Date: | Education | Hospital | All | |
Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic Diseases Release Date: Partner: The Japan College of Rheumatology | Quality Improvement | Inflammation & Immunology | Japan | |
A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative Disease | Quality Improvement | Internal Medicine | USA | |
Establishment of Support System for Healthy Life Extension of Patients with CV disease Release Date: | Quality Improvement | Internal Medicine | Japan | |
Racial and Ethnic Disparities in the Menopause Experience Release Date: | Education | Internal Medicine | USA | |
Immunotherapy in Urothelial Carcinoma Release Date: Partner: Merck KGaA Darmstadt, Germany and EMD Serono | Education | Oncology | All | |
Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASH Release Date: | Education | Internal Medicine | All | |
NSCLC Biomarker Testing Release Date: | Quality Improvement | Oncology | Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom | |
Development of Talazoparib for Prostate Cancer Release Date: Partner: National Comprehensive Cancer Network | Research | Oncology | USA | |
Approaches to Smoking Cessation Counseling Release Date: | Education | Internal Medicine | Australia, India, Japan, New Zealand, Singapore, Taiwan | |
Burden of Community Acquired Pneumonia Release Date: | Research | Vaccines | USA | |
Closing Knowledge Gaps in Moderate-to-Severe Alopecia Areata Release Date: | Education | Inflammation & Immunology | USA | |
Progress in Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer | Education | Oncology | USA | |
Efforts to Promote Team-based Care and Regional Medical Collaboration for Cancer Patients Release Date: Partner: Japan Society of Clinical Oncology | Quality Improvement | Oncology | Japan | |
ISID-Pfizer 2021 Grant Challenge Release Date: Partner: The International Society for Infectious Diseases (ISID) | Quality Improvement | Hospital | All |
CLOSED RFPs
| Title | Grant Type | Focus Area | Country | Application Due Date |
|---|---|---|---|---|
Pneumococcal Disease Prevention Release Date: | ||||
Chronic Pain Release Date: | ||||
Bacterial Infections Release Date: | ||||
Pharmacy Pneumococcal Disease Prevention Release Date: | ||||
Smoking Cessation Release Date: | ||||
Non-Small Cell Lung Cancer Release Date: | ||||
Cardiovascular Risk in Rheumatoid Arthritis Release Date: | ||||
Opioid Pain Release Date: | ||||
Adult Pneumococcal Disease Prevention Release Date: | ||||
Prevention of Stroke in Women Release Date: | ||||
Oncology Educational Needs Assessments Release Date: | ||||
Extension Grant Release Date: | ||||
Appropriate use of Hormone Therapy in Postmenopausal Women Release Date: | ||||
Antimicrobial Stewardship Release Date: | ||||
Appropriate Immunizations in Rheumatoid Arthritis Patients Release Date: | ||||
Adolescent Immunization Release Date: | ||||
Chronic Pain Care Release Date: | ||||
Advanced Renal Cell Carcinoma Release Date: | ||||
Adherence to Medications for Rheumatoid Arthritis Release Date: | ||||
HCP Perceptions on Immunization Release Date: | ||||
Smoking Cessation Conference Release Date: | ||||
Extension Grant - Window 2 Release Date: | ||||
Barriers to Adult Immunizations Release Date: | ||||
Oral Anticoagulants (Pfizer and BMS) Release Date: Review Process: | ||||
Release Date: Review Process: | ||||
Use of PROS in RA Release Date: | ||||
Attention-Deficit/Hyperactivity Disorder Release Date: | ||||
Symptomatic Vulvovaginal Atrophy in the Postmenopausal Woman Release Date: | ||||
Chronic Pain Care Outcomes Release Date: | ||||
Chronic Pain Care in the Patient-Centered Medical Home Release Date: | ||||
Medication-Overuse Headache (MOH) Release Date: | ||||
Reducing Cardiovascular Risk Globally Through Improved Dyslipidemia Awareness and Treatment Release Date: | ||||
Community Oncologist Education and Support Systems ‐ Renal Cell Carcinoma and Hematologic Malignancies Release Date: | ||||
Disparities in Adult Immunizations Release Date: | ||||
Global Bridges Smoking Cessation Release Date: | ||||
Advances in Anticoagulation (Pfizer and BMS) Release Date: Review Process: | ||||
Cardiovascular Risk In Rheumatoid Arthritis Release Date: | ||||
Management of Flares in Rheumatoid Arthritis Patients Release Date: | ||||
Immunizations in Young Adolescents Release Date: | ||||
Pediatric and Adolescent Migraine Release Date: | ||||
Enabling Effective Conversations About Menopausal Vasomotor Symptoms Release Date: | ||||
Adult Immunization in Low- and Middle-Income Countries Release Date: | ||||
Improving Chronic Pain Outcomes Release Date: | ||||
Chronic Pain Care- Interprofessional Team Release Date: | ||||
Smoking Cessation Release Date: | ||||
Patient Care in Rheumatoid Arthritis Release Date: | ||||
Chronic Pain Empowerment Platform Release Date: | ||||
Disparities in Adult Pneumococcal Vaccination Release Date: | ||||
Anticoagulation Education - NVAF or VTE Release Date: Review Process: | ||||
Transition of Care in VTE Release Date: | ||||
Achievement of Treat-to-Target in Rheumatoid Arthritis Release Date: | ||||
Improving Care of Chronic Pain- Physician Groups and Health Systems Release Date: | ||||
Facilitation of the Diagnosis of Rheumatoid Arthritis Release Date: | ||||
Pfizer and NCCN: Metastatic Breast Cancer Release Date: | ||||
Pediatric Immunization Series Completion Release Date: | ||||
Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic Arthritis Release Date: | ||||
Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk Patients Release Date: | ||||
Pfizer and American Academy of Dermatology (AAD): Patient Access to Care Release Date: | ||||
Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid Arthritis Release Date: | ||||
Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe Program Release Date: | ||||
Implementation of MenB Vaccine Recommendations in Older Adolescents/Young Adults Release Date: | ||||
Rheumatology Fellowships Release Date: | ||||
Release Date: Review Process: | ||||
IPI and Pfizer: Device Challenge- System for Dosing and Dispensing Multiparticulate Formulations of Pediatric Drugs Release Date: | ||||
Pfizer and American Pain Society: Improving Chronic Pain Care Release Date: | ||||
Accelerating Improvements in Medication Optimization Release Date: Review Process: | ||||
Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) Protocol for Routine Joint Assessment of Haemophilia Patients Release Date: | ||||
Improving Care of Patients with Atrial Fibrillation in Order to Reduce Stroke Risk Release Date: | ||||
IGLC_IHI_RFP Accelerating Improvements in Medication Optimization_Re-release Release Date: | ||||
Pfizer and Global Healthy Living Foundation: Rheumatoid Arthritis Shared Decision Making Release Date: Review Process: | ||||
IBD Fellowship RFP 12212016 Release Date: | ||||
Rheumatology Fellowship Release Date: | ||||
Improving the Identification and Management of Adult Growth Hormone Deficiency (AGHD) Release Date: | ||||
Improving Health Care Capacity in Immuno-Oncology Release Date: | ||||
Strategies to Support Increasing Exercise and Activity in Haemophilia Patients Release Date: | ||||
Improving Pediatric ADHD Care – Innovative Implementation of a National Guideline Release Date: | ||||
Reducing the Burden of Cardiovascular Disease in Indonesia Release Date: | ||||
Shared Management of Psoriatic Arthritis Release Date: | ||||
Building Capacity for Tobacco Dependence Treatment in Japan Release Date: | ||||
Clinical Pathways in Breast Cancer Release Date: | ||||
Quality improvements in the Management of Atopic Dermatitis Release Date: Review Process: | ||||
Dermatology Fellowship RFP Release Date: | ||||
Dermatology Early Career Investigator Quality Improvement Projects Release Date: Review Process: | ||||
Programs Toward Improving the Quality of Depression Treatment Release Date: | ||||
Improving Patient Care in Inflammatory Bowel Disease (IBD) through Shared Decision-Making Release Date: Review Process: | ||||
Developing Clinical Research and Publication Skills - AfME and EU Release Date: Review Process: | ||||
Developing Clinical Research and Publication Skills – UK Release Date: Review Process: | ||||
Inflammatory Bowel Disease Fellowships Release Date: | ||||
Improving Health Outcomes in Atopic Dermatitis (AD) through Shared Decision-Making Release Date: Review Process: | ||||
Patient Decision Aids for Inflammatory Conditions Release Date: Review Process: | ||||
Improving Assessment and Treatment of Acute Vaso-occlusive Crisis Release Date: | ||||
Rheumatology Fellowship Release Date: Review Process: | ||||
Developing Clinical Research and Publication Skills – UK (Re-release) Release Date: Review Process: | ||||
Developing Clinical Research and Publication Skills - AfME and EU (Re-release) Release Date: Review Process: | ||||
Dermatology Fellowship Release Date: Review Process: | ||||
Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions Release Date: Review Process: | ||||
Improving the Clinical Management of Uncontrolled Acromegaly Release Date: Review Process: | ||||
Antimicrobial Stewardship in the Asia-Pacific Region Release Date: Review Process: | ||||
Lysosomal Storage Disorders Fellowship for Nurse Practitioners Release Date: Review Process: | ||||
Hemophilia PUP Registry Release Date: Review Process: | ||||
Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and Management Release Date: Review Process: | ||||
Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions Release Date: Review Process: | ||||
Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic Arthritis Release Date: Review Process: | ||||
Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE) Release Date: Review Process: | ||||
Medication Optimization in Primary Care Release Date: Review Process: | ||||
Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism Release Date: Review Process: | ||||
Increasing Rates of BRCA Testing in Patients with Breast Cancer Release Date: Review Process: | ||||
Providing Access to Learning Resources for Nurses in Africa Release Date: Review Process: | ||||
Increasing Adult Pneumococcal Immunization Rates through AAFP State Chapters Release Date: | ||||
Improving Vaccine Utilization and Preventive Health Maintenance in IBD Release Date: Review Process: | ||||
Supporting Educational Programs for Radical Reform of Pain Treatment in Japan Release Date: Review Process: | ||||
Improving Pediatric Immunization Care – Innovative Strategies to Improve Childhood Immunization Rates Release Date: Review Process: | ||||
Rheumatology Nurse Practitioner and Physician Assistant Fellowship Release Date: Review Process: | ||||
Cardiac Amyloidosis Fellowship Release Date: Review Process: | ||||
Improving Pneumococcal Immunization of Adults with Immunocompromising Conditions Release Date: Review Process: | ||||
Efforts for Early Detection of Atrial Fibrillation and Prevention of Cardio Embolic Stroke Release Date: Review Process: | ||||
Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism Release Date: Review Process: | ||||
Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEing Release Date: Review Process: | ||||
QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF) Release Date: Review Process: | ||||
Quality Improvement initiatives optimizing AF and VTE management in Canada Release Date: Review Process: | ||||
Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets) Release Date: Review Process: | ||||
Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys Release Date: | Education | Hospital | Albania | |
Integrated Approach to Breast Health Equity Release Date: Review Process: | ||||
Patient Registries In Metastatic Breast Cancer Release Date: Review Process: | ||||
Improving Patient Care in Tobacco Dependency Release Date: Review Process: | ||||
Antimicrobial Stewardship in the Latin America Region Release Date: Review Process: | ||||
Management of Atopic Dermatitis – International Developed Markets Release Date: Review Process: | ||||
Improving Standard of Care for Chronic AD Release Date: Review Process: | ||||
NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care Release Date: Review Process: | ||||
Translating the Atopic Dermatitis (AD) Release Date: Review Process: | ||||
UK Oncology Quality Improvement Grants Release Date: Review Process: | ||||
Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast Cancer Release Date: Review Process: | ||||
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers Release Date: Review Process: | ||||
Vaccines for All: Longevity Unleashed for Everyone (VALUE) Release Date: | Quality Improvement | Vaccines | Japan | |
Breast Cancer Competitive Research Grant Program for Africa, the Middle East, Asia and Latin America Regions Release Date: | Research | Oncology | All | |
Bristol-Myers Squibb/Pfizer Alliance Announce Quality Improvement initiatives optimizing AF and VTE management in Canada | Quality Improvement | Internal Medicine | Canada | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers Release Date: Review Process: | ||||
Transthyretin Cardiac Amyloidosis Fellowship Release Date: | Fellowship | Rare Disease | USA | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Release Date: | Research | Rare Disease | USA | |
Local Level Educational Grants Program to Increase Awareness and Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Release Date: | Education | Rare Disease | USA | |
Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM) Release Date: | Education | Rare Disease | USA | |
Addressing Knowledge Gaps for the Appropriate Use of Biosimilars Release Date: | Education | Oncology | Japan | |
Acromegaly/Growth Hormone Excess Research Release Date: | Research | Rare Disease | USA | |
Growth Hormone Research Release Date: | Research | Rare Disease | USA | |
Efforts for early detection of atrial fibrillation and cardioembolic stroke prevention Release Date: | Quality Improvement | Internal Medicine | Japan | |
Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medical Release Date: | Education | Internal Medicine | Japan | |
Patient Registries In ATTR-CM Release Date: | Quality Improvement | Rare Disease | Japan | |
Optimizing Menopausal Symptom Management in Canada Release Date: | Quality Improvement | Internal Medicine | Canada | |
Optimizing Menopausal Symptom Management in Canada Release Date: | Quality Improvement | Internal Medicine | Canada | |
Gene and Anti-TFPI Therapies in Hemophilia Release Date: | Research | Rare Disease | All | |
Implementing Updated Pneumococcal Immunization Recommendations in Adults Release Date: | Quality Improvement | Vaccines | USA | |
Biomarker Testing / Lung Cancer Release Date: | Education | Oncology | Japan | |
Employment support / Lung Cancer Release Date: | Education | Oncology | Japan | |
Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France) Release Date: | Education | Internal Medicine | Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom | |
Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast Cancer Release Date: | Education | Oncology | Japan | |
Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin America Release Date: | Research | Rare Disease | All | |
Rheumatic diseases such as SLE, SS, SSc, vasculitis syndrome Release Date: | Education | Inflammation & Immunology | Japan | |
Optimal treatment and management of Rheumatoid Arthritis Release Date: | Education | Inflammation & Immunology | Japan | |
Education relating to Etiology, diagnosis, treatment and, management of Spondyloarthritis Release Date: | Education | Inflammation & Immunology | Japan | |
Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South Korea Release Date: | Research | Inflammation & Immunology | All | |
Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South Korea Release Date: | Research | Inflammation & Immunology | All | |
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis Release Date: | Quality Improvement | Rare Disease | All | |
Hemophilia: Improve general knowledge level of gene therapy Release Date: | Education | Rare Disease | Japan | |
Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders Release Date: | Education | Internal Medicine | USA | |
Serotyping of Streptococcus pneumoniae Release Date: | Education | Vaccines | Japan | |
Artificial Intelligence/Machine Learning Research in Hemophilia Release Date: | Research | Rare Disease | USA | |
Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients Release Date: | Education | Inflammation & Immunology | Japan | |
Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disorders Release Date: | Education | Rare Disease | Japan | |
Long-acting Growth Hormone Research Release Date: | Research | Rare Disease | All | |
COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe) Release Date: | Quality Improvement | Oncology | All | |
2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning | Education | Internal Medicine | All | |
NASH – Future of Non-invasive Diagnosis Technologies Release Date: | Education | Internal Medicine | All | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Release Date: | Quality Improvement | Rare Disease | USA | |
Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East) Release Date: Partner: International Society for Infectious Diseases (ISID) | Quality Improvement | Hospital | All | |
Advances in Oncology Therapy in Renal Cell Carcinoma Release Date: | Education | Oncology | Japan | |
Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis Release Date: | Education | Rare Disease | All | |
Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China Region Release Date: Partner: RCNi (subsidiary of the Royal College of Nursing) | Education | Internal Medicine | Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America Release Date: | Research | Rare Disease | Argentina, Brazil, Chile, Colombia | |
Vaccine Preventable Diseases – COVID-19 (closed early) Release Date: | Research | Vaccines | All | |
Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal Cancer | Research | Oncology | All, USA | |
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists Release Date: | Education | Inflammation & Immunology | USA | |
Incorporating Biosimilar Treatment Options in Solid Tumor Education Programs Release Date: | Education | Oncology | All | |
NSCLC – Current Practice Considerations Release Date: | Education | Oncology | Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom | |
Gram Negatives Pathogens & Antimicrobial Resistance: Local Data Generation in Latin America Release Date: | Research | Hospital | Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Uruguay | |
Addressing Health Disparities in Inflammatory Bowel Disease Release Date: | Quality Improvement | Inflammation & Immunology | USA | |
Enduring SpA Programs Release Date: | Education | Inflammation & Immunology | All | |
Atopic Dermatitis Patient Education Release Date: | Education | Inflammation & Immunology | USA | |
Knowledge Gaps in Updated Pneumococcal Immunization Recommendations Release Date: | Education | Vaccines | USA | |
Prostate Cancer Disparities Project | Quality Improvement | Oncology | USA | |
Telehealth Solutions in Rheumatoid Arthritis for Improving Education and Patient Care (Emerging Markets) Release Date: | Education | Inflammation & Immunology | All | |
Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care (Emerging Markets) Release Date: | Education | Inflammation & Immunology | All | |
Life-Long Learning and Implementation of Education in Pain Associated with Osteoarthritis (Europe EFIC) | Quality Improvement | Internal Medicine | Albania, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, France, Metropolitan, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Moldova, Republic of, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom | |
Use of Biosimilar Agents in Inflammatory Conditions Release Date: | Education | Inflammation & Immunology | USA | |
Diagnosis of Invasive Fungal Infections Release Date: | Education | Hospital | Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling) Islands, Colombia, Comoros, Congo, Congo, The Democratic Republic, Cook Islands, Costa Rica, Cote D'ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands (Malvinas), Faroe Islands, Fiji, Finland, France, France, Metropolitan, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guinea, Guinea-bissau, Guyana, Haiti, Heard and Mc Donald Islands, Holy See (Vatican City State), Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Korea, Korea, Democratic People's Rep, Kuwait, Kyrgyzstan, Lao People's Democratic Republ, Latvia, Lebanon, Lesotho, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, The Former Yugoslav, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Federated States o, Moldova, Republic of, Monaco, Mongolia, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Puerto Rico, Qatar, Reunion, Romania, Russia, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadin, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Seychelles, Sierra Leone, Singapore, Slovakia (Slovak Republic), Slovenia, Solomon Islands, Somalia, South Africa, South Georgia and the South Sa, Spain, Sri Lanka, St. Helena, St. Pierre and Miquelon, Sudan, Suriname, Svalbard and Jan Mayen Islands, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tajikistan, Tanzania, United Republic of, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States Minor Outlying I, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Virgin Islands (British), Virgin Islands (U.S.), Wallis and Futuna Islands, Western Sahara, Yemen, Yugoslavia, Zambia, Zimbabwe | |
Adoption of Biosimilars in Oncology Release Date: Partner: The National Comprehensive Cancer Network® (NCCN) | Research | Oncology | USA | |
Improving Disparities in Rheumatoid Arthritis Health Care in Post COVID-19 Era in memory of Cinzia Curiale Release Date: | Education | Inflammation & Immunology | Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom | |
Management of Non-Communicable Diseases (NCD) for Health Care Providers Release Date: | Education | Internal Medicine | Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Italy, Japan, Kazakhstan, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Turkey, USA, Ukraine, United Kingdom | |
Continuity of Care: Education for Rheumatology Patients Release Date: | Education | Inflammation & Immunology | USA | |
Assessment of on-time immunization coverage in children under 2 years of age in Canada Release Date: | Research | Vaccines | Canada | |
Optimal Early Therapy Management in CML Release Date: | Quality Improvement | Oncology | Canada, USA | |
Addressing Racial Disparities in Cancer Care | Quality Improvement | Oncology | USA | |
Addressing Knowledge Gaps in Growth Hormone Deficiency Release Date: | Education | Rare Disease | USA | |
Telehealth in Postmenopausal Patient Care Release Date: | Education | Internal Medicine | USA | |
Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP Release Date: | Quality Improvement | Inflammation & Immunology | Canada, USA | |
ADVANCE: Global Awards for Advancing Chronic Pain Research | Research | Internal Medicine | All | |
Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era Release Date: | Quality Improvement | Inflammation & Immunology | United Kingdom | |
New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC) Release Date: Partner: Merck KGaA Darmstadt, Germany and EMD Serono | Education | Oncology | France, Germany, Italy, Spain, USA, United Kingdom | |
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata Release Date: | Education | Inflammation & Immunology | USA | |
PARP-inhibitor Combination Treatments in Prostate Cancer Release Date: | Education | Oncology | All | |
Remote Mentoring Programs in RCC Release Date: | Education | Oncology | USA | |
Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe) Release Date: Partner: The Sharing Progress in Cancer Care (SPCC) | Quality Improvement | Oncology | All | |
Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA) Release Date: | Education | Inflammation & Immunology | Canada, USA | |
Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making Release Date: | Education | Oncology | Canada, USA | |
NSCLC Oncogene Driver Considerations in Testing & Treatment Release Date: | Education | Oncology | USA | |
Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata Release Date: | Education | Inflammation & Immunology | France, Germany | |
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic Dermatitis Release Date: | Education | Inflammation & Immunology | All | |
Pharmacist Education in Biosimilars (Western Europe, Canada, Japan) Release Date: | Education | Oncology | All | |
Biosimilars in Hematologic Malignancies & Supportive Care Release Date: | Education | Oncology | All | |
The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe) Release Date: | Education | Hospital | All | |
Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer Release Date: | Education | Oncology | USA | |
Advances in Atopic Dermatitis for Advanced Practitioners Release Date: | Education | Inflammation & Immunology | USA | |
2020 RD US- Next Generation PET Imaging for ATTR-CM | Research | Rare Disease | USA | |
Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant Program Release Date: Partner: International Society of Amyloidosis | Fellowship | Rare Disease | All | |
Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists Release Date: | Education | Inflammation & Immunology | USA | |
Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence Treatment | Education | Internal Medicine | China, Malaysia, Taiwan, Thailand | |
4th Quality Improvement initiatives optimizing AF and VTE management in Canada | Quality Improvement | Internal Medicine | Canada | |
2021 Rheumatology Competitive Grant Program Release Date: | Research | Inflammation & Immunology | USA | |
2021 Ulcerative Colitis Competitive Grant Program Release Date: | Research | Inflammation & Immunology | USA | |
Adoption of Biosimilars in Oncology Release Date: | Quality Improvement | Oncology | Canada | |
2021 Global Hemophilia ASPIRE Release Date: | Research | Rare Disease | All | |
Inflammatory and Immune-Mediated Dermatologic Disorders Release Date: | Research | Inflammation & Immunology | USA | |
Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals Release Date: | Education | Inflammation & Immunology | USA | |
Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant Lipoproteins Release Date: | Education | Internal Medicine | All | |
Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer | Education | Oncology | USA | |
I&I REALE 2021 RhEumatoid Arthritis Italian ReaL World Experience Release Date: | Research | Inflammation & Immunology | Italy | |
Inflammatory and Immune-Mediated Dermatologic Disorders (Global excluding U.S.) Release Date: | Research | Inflammation & Immunology | All | |
2021 Rheumatology Fellowship Release Date: | Fellowship | Inflammation & Immunology | USA | |
2021 Inflammatory Bowel Disease (IBD) Fellowship Release Date: | Fellowship | Inflammation & Immunology | USA | |
2021 Fellowship for Inflammatory Dermatological Diseases Release Date: | Fellowship | Inflammation & Immunology | USA | |
COVID-19 Vaccine Patient Education: Addressing Vaccine Hesitancy Release Date: | Education | Vaccines | All | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada Release Date: | Research | Rare Disease | Canada | |
Quality Improvement Grants to Support the Development of Cardiac Amyloid Centers Release Date: | Quality Improvement | Rare Disease | Canada | |
Junior Investigator Transthyretin Amyloid Polyneuropathy (ATTR-PN) Research Release Date: | Research | Rare Disease | All | |
Junior Investigator Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Release Date: | Research | Rare Disease | All | |
2021 Global ANGPTL3 ASPIRE Release Date: | Research | Internal Medicine | All | |
Inflammatory Bowel Disease (Europe, Israel, Turkey, Russia, Canada, Australia, New Zealand and Japan) Release Date: | Fellowship | Inflammation & Immunology | All | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers Release Date: | Quality Improvement | Rare Disease | USA | |
Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM) Release Date: | Education | Rare Disease | USA | |
Epidemiology of Atopic Dermatitis, Alopecia Areata and Vitiligo Needs Assessment (Asia, Latin America, the Middle East & Africa) Release Date: | Education | Inflammation & Immunology | All | |
PCF-Pfizer Health Equity Challenge Awards | Research | Oncology | All | |
Shared Decision Making Including Financial Cost and Cancer Treatment Release Date: | Education | Oncology | Japan | |
Early Identification and Diagnosis of Axial Spondyloarthritis Release Date: | Education | Inflammation & Immunology | USA | |
BRAF-mutant melanoma: treatment selection and side effect management Release Date: | Education | Oncology | Canada, USA | |
Education and Support for Patients with Locally-Advanced or Metastatic Bladder Cancer Release Date: Partner: Merck KGaA, Darmstadt, Germany and EMD Serono | Education | Oncology | USA | |
Management of Patients with BRAF-mutant metastatic colorectal cancer Release Date: | Education | Oncology | Canada, USA | |
NSCLC Therapy Management for Optimal Outcomes Release Date: | Quality Improvement | Oncology | Andorra, Austria, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom | |
Improve the care of patients living with metastatic breast cancer | Quality Improvement | Oncology | Canada | |
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists Release Date: | Education | Inflammation & Immunology | USA | |
Topical Hemostasis in Minimally Invasive Surgery Release Date: | Education | Hospital | USA | |
IBD Fellow Training in US Release Date: | Education | Inflammation & Immunology | USA | |
Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal Cancer | Quality Improvement | Oncology | USA | |
Enzalutamide in the Treatment of Prostate Cancer Release Date: Partner: National Comprehensive Cancer Network, Astellas | Research | Oncology | USA | |
Hemophilia: Improve Knowledge Level of Gene Therapy Release Date: | Education | Rare Disease | Japan |
Show
Hide
